Malawi

  • Research/Demonstration Projects: No research on daily oral PrEP has taken place in Malawi. There is an ongoing trial of an ARV-containing vaginal ring, slated to release data in the next year.
  • Drug Registration: Truvada is registered for treatment and prevention
  • Policy/Regulatory: The “Malawi Guidelines for Clinical Management of HIV in Children and Adults (2016) do not currently recommend PrEP use. The National HIV Prevention Strategy (2015-2020) recommends PrEP is included in the prevention strategy package for men who have sex with men (MSM) and discordant couples.
  • Advocacy: Civil society is at the forefront of efforts to ensure a comprehensive response, including high quality ART for people living with HIV and incorporation of PrEP. See, for example, the poster Advocacy for More HIV Prevention Options for Women in Malawi.

Last updated on September 1, 2017.

News Spotlight